Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Join | Sign in
Home>Resources>White Papers

  White Papers

Safety Document Exchange in the Global Clinical Research Environment

Intralinks
More information
Social Media in the Pharmaceutical Industry

Astra Zeneca
More information
Speeding up time-to-market

Vetter Pharma International GmbH
More information
The New Role of Academia in Drug Discovery and Development: New Thinki

Kauffman Foundation
More information
The ROI of Contract Research Services

Accelrys
More information
The Strategic Contributions of Indian Operations in AMRI’s Global Outs

AMRI
More information
Use of a Label-Free Platform in a preclinical Contract Research Organi

Caliper Life Sciences
More information
Value to the Fore

AMRI
More information
Value to the Fore: Flexible CRO Solutions Aim to Improve Pipeline Succ

Amri
More information
<< 1 2 3 >>
showing results 10 to 18 of 19
Scientific News
NIH-funded Study Points Way Forward for Retinal Disease Gene Therapy
Benefits for Leber congenital amaurosis peak after one to three years, then diminish.
Alcoholic Hepatitis Treatments Fail to Keep Patients Alive
The study is published in the New England Journal of Medicine.
NIH Launches Largest Clinical Trial Focused on HIV-related Cardiovascular Disease
Clinical trial to test whether statin administration can reduce the risk for major adverse cardiovascular events.
No Evidence to Change Current Transfusion Practices for Adults
Study found no difference in the primary clinical measure between complex cardiac surgery patients.
Personalized Melanoma Vaccines Marshal Powerful Immune Response
Vaccines target unique mutations in each patient’s tumor.
Repurposed Experimental Cancer Drug Restores Brain Function in Mouse Models
NIH-supported research enables clinical trial to explore treatment for most common form of dementia.
Experimental Ebola Vaccine Safe, Prompts Immune Response
Results from US government-sponsored phase 1 trial of VSV vaccine reported.
Ebola Test Vaccines Appear Safe in Phase 2 Liberian Clinical Trial
Liberia-U.S. partnership planning Phase 3 trial and study of Ebola survivors.
NIH Works to Improve Kidney Health for All
Statement of NIDDK Director Griffin P. Rodgers, M.D., for World Kidney Day 2015.
MorphoSys and Emergent BioSolutions Initiate Phase 1 Clinical Study
Phase 1 study to evaluate the novel oncology immunotherapeutic MOR209/ES414 for prostate cancer.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters